[Use of cefroxadine dry syrup in the management of acute skin infections in children (author's transl)]

Jpn J Antibiot. 1981 Dec;34(12):1748-64.
[Article in Japanese]

Abstract

1. Cefroxadine dry syrup was in principle administered at the dosage of 10 mg per kilogram of body weight 3 times a day. 2. Evaluation was done in 4 grades, i.e. excellent, good, fair and poor. 3. According to subjective judgement by attending doctors, 'excellent' or 'good' was recorded in 90.7%. 4. If the evaluation was partially standardized, 'excellent' or 'good' was obtained in 74.8% of total 163 cases and in 78.7% of 108 impetigo cases. 5. Side effects were observed in 3 cases (diarrhea 1, fever 2). No direct correlation of these complaints with the administration of the present drug was confirmed.

Publication types

  • Clinical Trial

MeSH terms

  • Abscess / drug therapy
  • Acute Disease
  • Cephalosporins / therapeutic use*
  • Cephradine / administration & dosage
  • Cephradine / adverse effects
  • Cephradine / analogs & derivatives
  • Cephradine / therapeutic use*
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Dosage Forms
  • Female
  • Humans
  • Impetigo / drug therapy*
  • Infant
  • Male
  • Skin Diseases, Infectious / drug therapy*

Substances

  • Cephalosporins
  • Dosage Forms
  • cefroxadine
  • Cephradine